D
Dianne Gallup
Researcher at Duke University
Publications - 37
Citations - 5549
Dianne Gallup is an academic researcher from Duke University. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 19, co-authored 33 publications receiving 4817 citations. Previous affiliations of Dianne Gallup include Durham University.
Papers
More filters
Journal ArticleDOI
A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
Christopher B. Newgard,Jie An,James R. Bain,Michael J. Muehlbauer,Robert Stevens,Lillian F. Lien,Andrea M. Haqq,Svati H. Shah,Michelle Arlotto,Cris A. Slentz,James Rochon,Dianne Gallup,Olga Ilkayeva,Brett R. Wenner,William S. Yancy,Howard Eisenson,Gerald Musante,Richard S. Surwit,David S. Millington,Mark D. Butler,Laura P. Svetkey +20 more
TL;DR: Findings show that in the context of a dietary pattern that includes high fat consumption, BCAA contributes to development of obesity-associated insulin resistance.
Journal ArticleDOI
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
Deepak L. Bhatt,Gregg W. Stone,Kenneth W. Mahaffey,C. Michael Gibson,P. Gabriel Steg,Christian W. Hamm,Matthew J. Price,Sergio Leonardi,Dianne Gallup,Ezio Bramucci,Peter W. Radke,Petr Widimský,František Toušek,Jeffrey Tauth,Douglas Spriggs,Brent T. McLaurin,Dominick J. Angiolillo,Philippe Généreux,Tiepu Liu,Jayne Prats,Meredith Todd,Simona Skerjanec,Harvey D. White,Robert A. Harrington +23 more
TL;DR: Cangrelor significantly reduced the rate of ischemic events, including stent thrombosis, during PCI, with no significant increase in severe bleeding.
Journal ArticleDOI
Sex differences in mortality following acute coronary syndromes.
Jeffrey S. Berger,Laine E. Elliott,Dianne Gallup,Matthew T. Roe,Christopher B. Granger,Paul W. Armstrong,R. John Simes,Harvey D. White,Frans Van de Werf,Eric J. Topol,Judith S. Hochman,L. Kristin Newby,Robert A. Harrington,Robert M. Califf,Richard C. Becker,Pamela S. Douglas +15 more
TL;DR: Sex-based differences existed in 30-day mortality among patients with ACS and vary depending on clinical presentation, however, these differences appear to be largely explained by clinical differences at presentation and severity of angiographically documented disease.
Journal ArticleDOI
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: Results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (IMPACT-HF) trial
Wendy A. Gattis,Christopher M. O'Connor,Dianne Gallup,Vic Hasselblad,Mihai Gheorghiade,Impact-Hf Investigators,Coordinators +6 more
TL;DR: Prischarge initiation of carvedilol in stabilized patients hospitalized for HF improved the use of beta-blockade at 60 days without increasing side effects or length of hospital stay.
Journal ArticleDOI
Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry.
TL;DR: The IMPACT-HF registry enrolled elderly patients admitted for worsening heart failure primarily resulting from progressive volume overload, and the 60-day rate of death or rehospitalization was high despite the use of evidence-based therapies.